Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19741725 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia
Interventions: Drug: Clofarabine for  remission induction;   Drug: Etoposide for remission induction;   Drug: Cyclophosphamide for remission induction;   Drug: Clofarabine in conditioning before transplantation;   Drug: Thiotepa in conditioning before transplantation;   Drug: Melfalan in conditioning before transplantation;   Procedure: Haploidentical transplantation of T-cell depleted graft;   Procedure: Donor lymphocyte infusion

Indicates status has not been verified in more than two years